BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 367287)

  • 21. [Correlation between results of intracutaneous and lymphocyte transformation tests with Candida albicans antigens].
    Lischka G; Bonatz G
    Z Hautkr; 1975 Oct; 50(20):853-8. PubMed ID: 769371
    [No Abstract]   [Full Text] [Related]  

  • 22. [Significance of the reactivity to tuberculin, streptokinase and streptodornase in atopic dermatitis].
    Silny W; Wojnerowicz-Grajewska M
    Przegl Dermatol; 1983; 70(3):249-52. PubMed ID: 6665183
    [No Abstract]   [Full Text] [Related]  

  • 23. Atopic dermatitis: an immunologic disease complex and its therapy.
    Kaye JW
    Ann Allergy; 1977 May; 38(5):345-52. PubMed ID: 16516
    [No Abstract]   [Full Text] [Related]  

  • 24. Use of transfer factor in patients with depressed cellular immunity and chronic infection.
    Rocklin RE
    Birth Defects Orig Artic Ser; 1975; 11(1):431-5. PubMed ID: 1096987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Basic and clinical aspects of atopic dermatitis.
    Hanifin JM
    Ann Allergy; 1984 Jun; 52(6):386-95. PubMed ID: 6145376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IgE-mediated hypersensitivity and contact sensitivity to multiple environmental allergens in atopic dermatitis.
    Tanaka M; Aiba S; Matsumura N; Aoyama H; Tabata N; Sekita Y; Tagami H
    Arch Dermatol; 1994 Nov; 130(11):1393-401. PubMed ID: 7979440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Candida albicans-specific lymphoproliferative and cytokine (IL-4 and IFN-gamma) responses in atopic eczema dermatitis syndrome. Evidence of CD4/CD8 and CD3/CD16+CD56 ratio elevations in vitro.
    Kosonen J; Luhtala M; Viander M; Kalimo K; Terho EO; Savolainen J
    Exp Dermatol; 2005 Jul; 14(7):551-8. PubMed ID: 15946244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of transfer factor on lymphocyte function in anergic patients.
    Kirkpatrick CH; Rich RR; Smith TK
    J Clin Invest; 1972 Nov; 51(11):2948-58. PubMed ID: 5080419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell-mediated immunity in healthy and uremic adults assessed by in vivo and in vitro techniques. Validation of delayed hypersensitivity skin testing.
    López M; Jerez J; González M; Arias M
    Allergol Immunopathol (Madr); 1989; 17(1):21-8. PubMed ID: 2750637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced in vivo cell-mediated immune responses to mumps, tuberculin, and streptokinase/streptodornase but not to Candida albicans in oral lichen planus.
    Simark-Mattsson C; Jontell M; Bergenholtz G; Dahlgren UI
    J Dent Res; 1999 Nov; 78(11):1704-10. PubMed ID: 10576166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunodeficiency in Hodgkin disease.
    Eltringham JR; Kaplan HS
    Birth Defects Orig Artic Ser; 1975; 11(1):278-88. PubMed ID: 1148383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell-mediated immunity in professional and voluntary blood donors.
    Sharma MK; Anaraki F; Harbour C; Ala F
    Vox Sang; 1978; 35(5):350-3. PubMed ID: 358587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of a kappa-casein-specific lymphocyte response in milk-responsive atopic dermatitis.
    Werfel T; Ahlers G; Schmidt P; Boeker M; Kapp A
    Clin Exp Allergy; 1996 Dec; 26(12):1380-6. PubMed ID: 9027438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antigen specific stimulation of immune responses during long-term repeated skin testing with multiple antigens.
    Lesourd BM; Winters WD; Darnell B
    J Clin Lab Immunol; 1986 Sep; 21(1):17-22. PubMed ID: 2433448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell-mediated immunity to Pityrosporum orbiculare in tinea versicolor.
    Sohnle PG; Collins-Lech C
    J Clin Invest; 1978 Jul; 62(1):45-53. PubMed ID: 96143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Immedeate and delayed-type reactivity to fungi and effects of antifungal drugs on atopic dermatitis].
    Kobayashi T; Yamada M; Aihara M; Ikezawa Z
    Arerugi; 2006 Feb; 55(2):126-33. PubMed ID: 16719000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo and in vitro cell-mediated immunity in tuberculous meningitis.
    El-Naggar AK; Higashi GI
    J Clin Lab Immunol; 1982 May; 8(1):37-42. PubMed ID: 7047745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced delayed hypersensitivity skin test reactivity with serial testing in healthy volunteers.
    Keystone EC; Demerieux P; Gladman D; Poplonski L; Piper S; Buchanan R
    Clin Exp Immunol; 1980 Apr; 40(1):202-5. PubMed ID: 6993077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Delayed skin reaction in a group of 400 hospital patients: control study (author's transl)].
    Orriols R; Morell F; Fité E; Ruiz J; Tornos C; Sanz R; Morera J
    Med Clin (Barc); 1981 Oct; 77(6):240-2. PubMed ID: 7321638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diagnosis of normal and abnormal delayed hypersensitivity to Candida albicans. Importance of evaluating lymphocyte activation by flow cytometry].
    Brunet JL; Peyramond D; Cozon GJ
    Allerg Immunol (Paris); 2001 Mar; 33(3):115-9. PubMed ID: 11386125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.